XML 15 R5.htm IDEA: XBRL DOCUMENT v3.25.1
Condensed Consolidated Statements of Stockholders’ Equity (Deficit) - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid In Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2023   57,820,621      
Beginning balance at Dec. 31, 2023 $ (20,689) $ 1 $ 538,716 $ (427) $ (558,979)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock upon follow-on offering, net of issuance costs (in shares)   3,554,000      
Issuance of common stock upon follow-on offering, net of issuance costs 46,794   46,794    
Issuance of common stock in connection with the incentive equity plan (in shares)   899,411      
Issuance of common stock in connection with the incentive equity plan 487   487    
Stock-based compensation 5,090   5,090    
Net loss (13,109)       (13,109)
Other comprehensive (loss) income (130)     (130)  
Ending balance (in shares) at Mar. 31, 2024   62,274,032      
Ending balance at Mar. 31, 2024 $ 18,443 $ 1 591,087 (557) (572,088)
Beginning balance (in shares) at Dec. 31, 2024 63,497,548 63,497,548      
Beginning balance at Dec. 31, 2024 $ 5,522 $ 1 615,825 (905) (609,399)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Issuance of common stock in connection with the incentive equity plan (in shares)   951,272      
Issuance of common stock in connection with the incentive equity plan 734   734    
Stock-based compensation 5,966   5,966    
Net loss (18,892)       (18,892)
Other comprehensive (loss) income $ 66     66  
Ending balance (in shares) at Mar. 31, 2025 64,448,820 64,448,820      
Ending balance at Mar. 31, 2025 $ (6,604) $ 1 $ 622,525 $ (839) $ (628,291)